Does USTEKINUMAB Cause Blepharospasm? 462 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 462 reports of Blepharospasm have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.5% of all adverse event reports for USTEKINUMAB.
462
Reports of Blepharospasm with USTEKINUMAB
0.5%
of all USTEKINUMAB reports
430
Deaths
403
Hospitalizations
How Dangerous Is Blepharospasm From USTEKINUMAB?
Of the 462 reports, 430 (93.1%) resulted in death, 403 (87.2%) required hospitalization, and 425 (92.0%) were considered life-threatening.
Is Blepharospasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 462 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Blepharospasm?
CETIRIZINE (735)
DESOXIMETASONE (730)
ADALIMUMAB (709)
TOCILIZUMAB (696)
RITUXIMAB (693)
NAPROXEN (692)
ERENUMAB-AOOE (689)
METHOTREXATE (689)
LEFLUNOMIDE (681)
SECUKINUMAB (677)
Which USTEKINUMAB Alternatives Have Lower Blepharospasm Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE